Lung cancer comes in two main types: non-small cell and small cell. Each has different patterns, growth rates, and treatment needs. Smoking is the top risk factor, but…
Harry Erba, MD, PhD, Duke University, Durham, NC; Marina Konopleva, MD, PhD, Albert Einstein College of Medicine, New York City, NY; Thomas Cluzeau, MD, PhD, Central University Hospital…
NEW YORK (Reuters Health) – A patient-centered program of telephone support, close monitoring and tight control of modifiable risk factors such as blood pressure and cholesterol levels results…
NEW YORK (Reuters Health) – The results of a placebo-controlled trial suggest that controlled-release oxycodone is an effective treatment for acute pain due to herpes zoster, whereas gabapentin…
ORLANDO (Reuters Health) – In patients with coronary artery disease and an ejection fraction of 35% or less, surgical reduction of the enlarged left ventricle along with coronary…
NEW YORK (Reuters Health) – For the management uncomplicated hypertension, using initial low-dose, fixed-dose combination therapy is better than guideline-based treatment, according to a report in the April…
ORLANDO (Reuters Health) – New findings, announced here during the annual meeting of the American College of Cardiology, show that rosuvastatin significantly reduces the risk of venous thromboembolism…
NEW YORK (Reuters Health) – Takotsubo cardiomyopathy, also known as “broken heart syndrome”, has an excellent long-term prognosis and nearly all patients have full recovery of left ventricular…
NEW YORK (Reuters Health) – Use of a high cut-off dialyzer can help patients with acute renal failure secondary to multiple myeloma become dialysis free, the results of…
NEW YORK (Reuters Health) Variants in certain genes for the natriuretic peptide system are predictive of ventricular dysfunction immediately after coronary artery bypass grafting (CABG), new study findings…
NEW YORK (Reuters Health) In statin-treated patients with coronary artery disease (CAD), high levels of the enzyme phospholipid transferprotein (PLTP) significantly increase the risk of cardiovascular events, independent…
NEW YORK (Reuters Health) For patients with epidermal growth factor (EGF) receptor-positive colorectal cancer and unresectable metastases, adding cetuximab to first-line treatment with irinotecan, fluorouracil, and leucovorin (FOLFIRI)…
